SWK Holdings (SWKH) Provides Portfolio Update

Go back to SWK Holdings (SWKH) Provides Portfolio Update

SWK Holdings Provides Portfolio Update

January 6, 2025 7:43 AM UTC

DALLAS, TX / ACCESSWIRE / January 6, 2025 / SWK Holdings Corporation (NASDAQ: SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, provided today a portfolio update for material events occurring since September 30, 2024.

Originations

In November, SWK advanced $5.0M to existing borrower Journey Medical to help fund the company's launch of EmrosiTM.

In November, as part of a broader amendment SWK advanced $0.6M to existing borrower Biotricity. On amendment closing, SWK received 600,000 warrants to... More